<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02021487</url>
  </required_header>
  <id_info>
    <org_study_id>5515</org_study_id>
    <nct_id>NCT02021487</nct_id>
  </id_info>
  <brief_title>Prokinecitine in Acute Myocardial Infarction</brief_title>
  <acronym>Prok-Idm</acronym>
  <official_title>Pilot Study Prok-Idm: Interest of Dosage of Prokinecitine in Acute Myocardial Infarction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aims to investigate the presence of a substance in the blood called prokinecitine,
      which is released by the heart when a heart attack occurs. Several venous blood samples at
      the arm are withdrawn at admission, H6, H12, H24, H48 and H72 in order to measure the
      concentration of this substance in the blood. The usefulness of this new blood marker is
      going to be determsined to seek if it would be of help to better diagnose or estimate the
      gravity of heart infarction after a heart attack.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 2013</start_date>
  <completion_date type="Anticipated">November 2019</completion_date>
  <primary_completion_date type="Anticipated">November 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Infarct size by MRI necrotic myocardial mass</measure>
    <time_frame>7 days</time_frame>
    <description>Infarct size by MRI necrotic myocardial mass</description>
  </primary_outcome>
  <enrollment type="Anticipated">200</enrollment>
  <condition>ST Elevatation Myocardial Infarction (STEMI)</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with acute St elevation myocardial infarction of less than 6 hours
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with acute St elevation myocardial infarction of less than 6 hours

          -  Age&gt;18 y/o

        Exclusion Criteria:

          -  Previous myocardial infarction

          -  LBB, RBB

          -  Renal Insuffiency MDRD&lt;30 mL/min

          -  Patient with Pace-Maker or ICD.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Patrick OHLMANN, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Strasbourg, France</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Patrick OHLMANN, MD</last_name>
    <phone>03 69 55 09 53</phone>
    <phone_ext>0033</phone_ext>
    <email>patrick.ohlmann@chru-strasbourg.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospital</name>
      <address>
        <city>Strasbourg</city>
        <zip>67000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patrick OHLMANN, MD</last_name>
    </contact>
    <investigator>
      <last_name>Patrick OHLMANN, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 19, 2013</study_first_submitted>
  <study_first_submitted_qc>December 19, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 27, 2013</study_first_posted>
  <last_update_submitted>September 7, 2017</last_update_submitted>
  <last_update_submitted_qc>September 7, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 11, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

